Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by GoTogetheron Aug 26, 2017 4:13am

116 Views

Post# 26624377

RE:RE:Dilution?!

... Ponching, you're suggesting 400 million shares are no problem at all.
Longer-term you might be right, but short-term ... Hmmm.

Market participants will make this calculation rather quickly :

126,481,526 x $0.475
------------------------------- = $0.15
400,000,000

New share price TLT : $0.15 minus a discount 20%* = $0.12
... Hmmm again.

* if not more.

Bullboard Posts

From now on, dynaCERT instead of Bitcoin or NVIDIA?